1. Market Research
  2. > Healthcare Market Trends
  3. > Health care System Development in Kenya and Rwanda : Unlocking New Opportunities in Sub-Saharan Africa

Health care System Development in Kenya and Rwanda : Unlocking New Opportunities in Sub-Saharan Africa

  • April 2015
  • -
  • Frost & Sullivan
  • -
  • 103 pages

Summary

Table of Contents

Key Findings

•Health care is regarded as the 4th most-attractive investment sector in Africa. Economic factors and the regulatory environment are the key aspects companies take into consideration when evaluating new markets.
•The increased prevalence of chronic diseases, the rising income levels, and the augmented health awareness drive the upsurge in the per capita total health expenditure in Kenya and Rwanda.
•More than x % of the total mobile penetration, along with ICT infrastructure and connectivity, will be the backbone of new mobile applications and mHealth startups in Kenya and Rwanda.
•Kenya has the most developed economy in East Africa. From 2004 to 2014, the country’s GDP averaged x %. However, due to lack of proper facilities, about x medical tourism patients from Kenya travel abroad each year, according to the Kenya Bureau of Statistics.
•HIV/AIDS is the major cause of adult death in Kenya. Effective low-cost point-of-care (POC) HIV diagnostic kits for nucleic acid testing (NAT) and immunodiagnostics hold potential as around 60% of the population live in rural areas without proper access to care.
•Around 60% of the total pregnancies in Kenya are handled by the private sector.
•According to the World Bank, in Kenya, out-of-pocket (OOP) expenses account for $ x out of every $ x spent on private health care. Annual private health care investments in East Africa grew by an average of x %, each year, from 2003 to 2013.
•In Rwanda, patients are often in the late stage of severe disease when they approach x of the x academic referral hospitals.
•The health transformation in Rwanda over the last x years was enabled, to a large extent, by community health workers (CHWs) who offer a solution to the financial, geographical, and infrastructural barriers in the resource-constrained country, thereby improving access to health in rural communities.
•Rwanda's per capita total expenditure on health has increased by more than x % between x and 2012.
•Although the number of health facilities in the country has increased over the past decade, approximately x % of the patients still travel more than x km to reach the closest facility. Physicians lack both the equipment and the training to provide specialized care.
•At the national level, the procurement and the distribution of drugs and medical supplies have made progress; however, the same cannot be said about the intermediate and the peripheral levels.
•By the end of 2017, Rwanda aims to provide 4G LTE technology to x % of its population.
•More than half of the country’s total health expenditure is funded by external resources. The salaries of doctors and nurses have been cut by x % due to the decrease in external assistance post 2011. Community-based national health insurance schemes do not include coverage at private health centres.
•Rwanda continues to be the most densely populated country in Africa with x persons living per square km. The high population growth rate is creating a huge demand for health care infrastructure.
•The formation of the East Africa Community (EAC) could provide opportunities for the insurance companies in the region.

Health care System

•From 2000 to 2013, Rwanda was the fastest-growing African nation with a yearly growth average of x %.
•The Ministry of Health (MoH) has started a public health scheme and set up training institutes, such as the Kigali Health Institute (KHI) and the College of Medicine and Health Sciences, University of Rwanda, Butare.
•In 2013, x % of the population was covered under public health insurance. The MoH is the major provider of primary, secondary, tertiary, and preventive health services.
•To improve the current situation, the government has increased national expenditure on health care by around x % (from 1996 to 2013). Over the same period, Rwanda was able to drastically reduce mortality rates due to diarrhoea ( x %) and maternal/neo-natal conditions ( x %).
•Rwanda’s health profile remains dominated by communicable diseases. The World Health Organization (WHO) classifies the HIV/AIDS prevalence in Rwanda as a generalized epidemic with a current prevalence of x % for the total population aged x x , which has declined from x % in 2004.
•There is a serious shortage of health care professionals in the country, with only x doctors and x paramedics per x people.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.